Dyadic International Inc DYAI

US Biotechnology
$0.42 โ–ผ -4.41% ($-0.02)
Open $0.44
Prev Close $0.44
Day Range $0.40 โ€“ $0.46
52W Range $0.34 โ€“ $1.60
Market Cap $17.44M
Beta 1.11
EPS (TTM) $-0.23

๐Ÿ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2004-11-05
Shares Out.36,440,000
Websitedyadic.com/ โ†—
Phone15617438333
Employees5
Revenue$961,138
Gross Profit-$23,027
Net Income-$2.1M
Free Cash Flow-$7.4M
Total Assets$6.5M
Total Liabilities$8.9M
Equity-$2.4M
About Dyadic International Inc

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Dyadic International Inc is a publicly traded company under the ticker symbol DYAI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

๐Ÿ“Š Analyst Ratings

7 analysts (2026-09-01)

Strong Buy 2
Buy 4
Hold 1

๐Ÿ“ฐ Latest News for DYAI

๐Ÿ‘ฅ Related Stocks